Michelle LaSpaluto - 01 Dec 2023 Form 3 Insider Report for CHIMERIX INC

Role
Chief Financial Officer
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Dec 2023
Net transactions value
$0
Form type
3
Filing time
04 Dec 2023, 17:25:08 UTC
Next filing
02 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CMRX Common Stock 87,939 01 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 9,000 $18.75 Direct F2
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 750 $36.75 Direct F2
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 9,000 $39.41 Direct F2
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 1,500 $53.74 Direct F2
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 15,000 $53.74 Direct F2
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 18,700 $8.06 Direct F2
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 1,250 $4.51 Direct F2
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 13,000 $4.68 Direct F2
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 8,098 $2.41 Direct F2
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 48,438 $2.49 Direct F2
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 62,067 $2.08 Direct F3
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 90,000 $9.28 Direct F4
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 95,000 $5.62 Direct F4
holding CMRX Stock Option (Right to Buy) 01 Dec 2023 Common Stock 64,275 $1.97 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount includes 10,725 unvested shares pursuant to a restricted stock unit award issued on January 17, 2023.
F2 Fully vested and exercisable.
F3 1/48th of the shares will vest each month over a four year period following the vesting commencement date. This stock option was previously exercised as to 25,933 shares.
F4 1/48th of the shares will vest each month over a four year period following the vesting commencement date.